valine and bilirubin

valine has been researched along with bilirubin in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (14.29)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (14.29)	29.6817
2010's	5 (71.43)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cerami, A	1
Awad, SS; Bartlett, RH; Magee, J; Punch, J; Swaniker, F	1
Appelman, H; Bifano, M; Dimitrova, D; Fontana, RJ; Hindes, R; Hughes, EA	1
Cai, S; Li, Y; Liu, X; Ren, B; Sun, T; Wang, Q; Xu, Q; Yu, H; Zhou, J	1
Bollipo, S; Cheng, W; Chivers, S; Dore, G; Fragomeli, V; Galhenage, S; Gazzola, A; George, J; Gow, P; Iser, D; Jones, T; Levy, M; Lubel, J; MacQuillan, G; Mitchell, JL; Nazareth, S; Pianko, S; Roberts, SK; Sasadeusz, J; Strasser, S; Stuart, KA; Thompson, A; Tse, E; Wade, A; Weltman, M; Wigg, A; Zekry, A	1
Bassiony, MAA; Hanafy, AS; Hussein, S; Mohamed, MS	1
De Maria, C; Ghidotti, I; Giannini, EG; Grillo, F	1

Reviews

1 review(s) available for valine and bilirubin

Article	Year
Review of the development of cyanate as a drug in the treatment of sickle cell anemia. Annals of the New York Academy of Sciences, 1974, Nov-29, Volume: 241, Issue:0 Topics: Adolescent; Adult; Anemia, Sickle Cell; Animals; Bilirubin; Binding Sites; Carbon Dioxide; Carbon Radioisotopes; Cell Survival; Chromium; Cyanates; Erythrocytes; Female; Hematocrit; Hemoglobins; Humans; L-Lactate Dehydrogenase; Male; Mice; Organ Specificity; Oxygen; Protein Binding; Time Factors; Valine	1974

Article

Year

Review of the development of cyanate as a drug in the treatment of sickle cell anemia.

Annals of the New York Academy of Sciences, 1974, Nov-29, Volume: 241, Issue:0

Topics: Adolescent; Adult; Anemia, Sickle Cell; Animals; Bilirubin; Binding Sites; Carbon Dioxide; Carbon Radioisotopes; Cell Survival; Chromium; Cyanates; Erythrocytes; Female; Hematocrit; Hemoglobins; Humans; L-Lactate Dehydrogenase; Male; Mice; Organ Specificity; Oxygen; Protein Binding; Time Factors; Valine

1974

Trials

1 trial(s) available for valine and bilirubin

Article	Year
Results of a phase I trial evaluating a liver support device utilizing albumin dialysis. Surgery, 2001, Volume: 130, Issue:2 Topics: Adolescent; Adult; Ammonia; Bilirubin; Blood Coagulation; Hemodiafiltration; Hepatic Encephalopathy; Humans; Isoleucine; Kidney; Leucine; Liver; Liver Failure, Acute; Middle Aged; Phenylalanine; Serum Albumin; Treatment Outcome; Tyrosine; Valine	2001

Other Studies

5 other study(ies) available for valine and bilirubin

Article	Year
Case report of successful peginterferon, ribavirin, and daclatasvir therapy for recurrent cholestatic hepatitis C after liver retransplantation. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2012, Volume: 18, Issue:9 Topics: Alkaline Phosphatase; Antiviral Agents; Bilirubin; Biomarkers; Carbamates; Cholestasis; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C; Humans; Imidazoles; Immunosuppressive Agents; Interferon-alpha; Liver Failure; Liver Transplantation; Middle Aged; Polyethylene Glycols; Pyrrolidines; Recombinant Proteins; Recurrence; Reoperation; Ribavirin; RNA, Viral; Time Factors; Treatment Outcome; Valine; Viral Load	2012
Valsartan decreases neointimal hyperplasia in balloon-injured rat aortic arteries by upregulating HO-1 and inhibiting angiotensin II type 1 receptor. Life sciences, 2014, Aug-21, Volume: 110, Issue:2 Topics: Analysis of Variance; Angioplasty, Balloon, Coronary; Animals; Aorta, Thoracic; Bilirubin; DNA Primers; Gene Expression Regulation; Heme Oxygenase-1; Hyperplasia; Male; Neointima; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Reverse Transcriptase Polymerase Chain Reaction; Tetrazoles; Valine; Valsartan	2014
Real-world efficacy and safety of ritonavir-boosted paritaprevir, ombitasvir, dasabuvir ± ribavirin for hepatitis C genotype 1 - final results of the REV1TAL study. Antiviral therapy, 2017, Volume: 22, Issue:8 Topics: 2-Naphthylamine; Adult; Aged; Anilides; Antiviral Agents; Bilirubin; Biomarkers; Carbamates; Cyclopropanes; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C; Humans; Lactams, Macrocyclic; Liver Cirrhosis; Liver Function Tests; Macrocyclic Compounds; Male; Middle Aged; Proline; Ribavirin; Ritonavir; Sulfonamides; Treatment Outcome; Uracil; Valine	2017
Sofosbuvir and daclatasvir plus ribavirin treatment improve liver function parameters and clinical outcomes in Egyptian chronic hepatitis C patients. European journal of gastroenterology & hepatology, 2017, Volume: 29, Issue:12 Topics: Adult; Alanine Transaminase; Antiviral Agents; Aspartate Aminotransferases; Bilirubin; Carbamates; Drug Therapy, Combination; Egypt; End Stage Liver Disease; Female; Hepatitis C, Chronic; Humans; Imidazoles; International Normalized Ratio; Male; Middle Aged; Platelet Count; Prospective Studies; Pyrrolidines; Ribavirin; Serum Albumin; Severity of Illness Index; Sofosbuvir; Sustained Virologic Response; Valine	2017
Successful DAA Treatment and Global Improvement in a Cirrhotic Patient with Concomitant HCV Infection and Autoimmune Hepatitis. Digestive diseases and sciences, 2019, Volume: 64, Issue:2 Topics: Alanine Transaminase; Antiviral Agents; Aspartate Aminotransferases; Bilirubin; Carbamates; Female; gamma-Globulins; Hepatitis C, Chronic; Hepatitis, Autoimmune; Humans; Imidazoles; Liver; Liver Cirrhosis; Middle Aged; Pyrrolidines; Ribavirin; RNA, Viral; Serum Albumin; Sofosbuvir; Valine; Viral Load	2019